Dyadic International, Inc (DYAI)

Etorro trading 970x250
Dyadic International, Inc (DYAI) Logo

About Dyadic International, Inc

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 technology and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-S-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U.; and research collaborations with Jiangsu Hengrui Medicine, Serum Institute of India Pvt., Ltd., and WuXi Biologics. It also has a collaboration with TurtleTree Scientific Pte. Ltd. to develop various recombinant protein growth factors; and a partnership with Medytox, Inc. to co-develop C1 manufactured COVID-19 vaccines and/or boosters. The company was founded in 1979 and is headquartered in Jupiter, Florida. Address: 140 Intracoastal Pointe Drive, Jupiter, FL, United States, 33477-5094

Dyadic International, Inc News and around…

Latest news about Dyadic International, Inc (DYAI) common stock and company :

Here's What Dyadic International, Inc.'s (NASDAQ:DYAI) Shareholder Ownership Structure Looks Like
20 Oct, 2021 Yahoo! Finance

A look at the shareholders of Dyadic International, Inc. ( NASDAQ:DYAI ) can tell us which group is most powerful...

Dyadic International Earnings Perspective: Return On Capital Employed
30 Sep, 2021 FinancialContent

Benzinga Pro data, Dyadic International (NASDAQ:DYAI) reported Q2 sales of $937.09 thousand. Earnings fell to a loss of $3.85 million, ...

12 Health Care Stocks Moving In Friday's After-Market Session
10 Sep, 2021 FinancialContent

Gainers Hepion Pharmaceuticals (NASDAQ:HEPA) shares rose 10.84% to $1.84 during Friday's after-market session. Hepion ...

Dyadic to Present at H.C. Wainwright 23rd Annual Global Investment Conference
10 Sep, 2021 FinancialContent
54 Biggest Movers From Yesterday
26 Aug, 2021 FinancialContent

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 202.8% to settle at $46.33 on Wednesday after gaining ...

Market Briefing For Thursday, Aug. 26
26 Aug, 2021 FinancialContent

Underperformance by many stocks, but few that are really in trouble, is reflective of rising complacency, while technicians are frustrated at the lack of breakouts or breakdowns. That's actually fine, and for this time of year really valued.

12 Health Care Stocks Moving In Wednesday's Intraday Session
25 Aug, 2021 FinancialContent

Gainers Regencell Bioscience (NASDAQ:RGC) stock rose 100.19% to $30.63 during Wednesday's regular session. Regencell ...

12 Health Care Stocks Moving In Monday's Pre-Market Session
23 Aug, 2021 FinancialContent

Gainers Vivos Therapeutics (NASDAQ:VVOS) stock increased by 64.84% to $6.33 during Monday's pre-market session. The ...

66 Biggest Movers From Yesterday
18 Aug, 2021 FinancialContent

Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received ...

12 Health Care Stocks Moving In Tuesday's Intraday Session
17 Aug, 2021 FinancialContent

Gainers Aerpio Pharmaceuticals (NASDAQ:ARPO) stock increased by 25.72% to $2.59 during Tuesday's regular session. ...

48 Stocks Moving In Tuesday's Mid-Day Session
17 Aug, 2021 FinancialContent

Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares jumped 93% to $$8.10 after the company received a written ...

DYAI: Sorrento Deal Provides Upfront Cash
16 Aug, 2021 Yahoo! Finance

By John Vandermosten, CFA NASDAQ:DYAI READ THE FULL DYAI RESEARCH REPORT Second Quarter 2021 Operational & Financial Results Dyadic International Inc. (NASDAQ:DYAI) released second quarter 2021 operational and financial results on August 12, 2021 and concurrently filed its Form 10-Q with the SEC. Following the release, an investor conference call was held. Highlights for the year to date

Week In Review: RemeGen Out-Licenses Rights For HER2 ADC To Seagen In $2.6 Billion Deal
14 Aug, 2021 FinancialContent

Yantai's RemeGen out-licensed global rights (ex-Asia) for its novel HER2-targeted ADC to Seagen in a $2.6 billion deal. Seagen, an antibody conjugate company, will pay $200 million upfront and up to $2.4 billion in milestones.

Why Dynavax, Novavax, and Sorrento Soared This Week
13 Aug, 2021 FinancialContent

There were different reasons behind each of these COVID-19 vaccine stocks' big gains.

Dyadic Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
12 Aug, 2021 FinancialContent
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
12 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Aug, 2021 FinancialContent

Gainers Xenetic Biosciences (NASDAQ:XBIO) shares rose 20.37% to $3.9 during Thursday's pre-market session. The ...

Dyadic Stock Jumps On Development Pact With Sorrento For Diagnostics & Therapies For Coronaviruses
11 Aug, 2021 FinancialContent

Dyadic International Inc(NASDAQ: DYAI) andSorrento Therapeutics Inc(NASDAQ: SRNE) have announced abinding ...

Mid-Afternoon Market Update: Dow Surges Over 200 Points; HyreCar Shares Plunge
11 Aug, 2021 FinancialContent

Toward the end of trading Wednesday, the Dow traded up 0.61% to 35,480.63 while the NASDAQ fell 0.30% to 14,743.90. The S&P also ...

Sorrento and Dyadic Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
11 Aug, 2021 FinancialContent
Dyadic and Sorrento Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
11 Aug, 2021 FinancialContent
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
08 Aug, 2021 FinancialContent

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader ...

DYAI: C1 Deals Extend Reach to 40% of World
05 Aug, 2021 Yahoo! Finance

By John Vandermosten, CFA NASDAQ:DYAI READ THE FULL DYAI RESEARCH REPORT Since Our Last Update Dyadic’s (NASDAQ:DYAI) recent events include: ➢ Development of COVID-19 vaccine in India - May 2021 ➢ C1 production platform utilized in ZAPI published in VACCINES - June 2021 ➢ Technology transfer and licensing agreement with Rubic Consortium (S. Africa) - July 2021 ➢ Sale of interest in VLP and BDI

61 Biggest Movers From Yesterday
03 Aug, 2021 FinancialContent

Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares climbed 124.8% to close at $5.08 on Monday after the company ...

Dyadic to Report Second Quarter 2021 Financial Results
29 Jul, 2021 FinancialContent
62 Biggest Movers From Yesterday
29 Jul, 2021 FinancialContent

Gainers Flora Growth Corp. (NASDAQ: FLGC) surged 63.1% to close at $8.27. The Miami-based cannabis producer confirmed Tuesday it ...

50 Stocks Moving In Wednesday's Mid-Day Session
28 Jul, 2021 FinancialContent

Gainers Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares jumped 59.9% to $2.43. Infinity Pharmaceuticals shares tumbled over ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
28 Jul, 2021 FinancialContent

Gainers Infinity Pharmaceuticals (NASDAQ:INFI) shares moved upwards by 40.13% to $2.13 during Wednesday's pre-market ...

28 Stocks Moving in Wednesday's Pre-Market Session
28 Jul, 2021 FinancialContent

Gainers Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares rose 38.2% to $2.10 in pre-market trading. Infinity Pharmaceuticals ...

44 Stocks Moving In Tuesday's Mid-Day Session
27 Jul, 2021 FinancialContent

Gainers Oragenics, Inc. (NASDAQ: OGEN) surged 55.9% to $0.9749 after the company announced it entered into a licensing agreement ...

Dyadic International, Inc (DYAI) is a NASDAQ Common Stock listed in , ,

970x250